Ország: Kanada
Nyelv: angol
Forrás: Health Canada
BOSENTAN (BOSENTAN MONOHYDRATE)
ALEMBIC PHARMACEUTICALS LIMITED
C02KX01
BOSENTAN
125MG
TABLET
BOSENTAN (BOSENTAN MONOHYDRATE) 125MG
ORAL
10/30/60/1000
Prescription
VASODILATING AGENTS
Active ingredient group (AIG) number: 0145922002; AHFS:
APPROVED
2021-12-16
______________________________________________________________________________ Alembic-Bosentan Page 1 of 42 PRODUCT MONOGRAPH PR ALEMBIC-BOSENTAN Bosentan Tablets 62.5 mg and 125 mg Bosentan (as Bosentan Monohydrate) Endothelin Receptor Antagonist DATE OF REVISION: December 13, 2021 MANUFACTURED BY: Alembic Pharmaceuticals Limited Alembic Road Vadodara – 390003 Gujarat, India CANADIAN IMPORTER AND DISTRIBUTOR: Alembic Pharmaceuticals Canada Ltd. 225 Gibraltar Road, Unit 5 Vaughn, Ontario L4H 4P9 Control # 258718 ______________________________________________________________________________ Alembic-Bosentan Page 2 of 42 TABLE OF CONTENTS PART I: HEALTH PROFESSIONAL INFORMATION ......................................................... 3 SUMMARY PRODUCT INFORMATION ........................................................................... 3 INDICATIONS AND CLINICAL USE .............................................................................. 3 CONTRAINDICATIONS ................................................................................................... 3 WARNINGS AND PRECAUTIONS ................................................................................. 4 ADVERSE REACTIONS ................................................................................................... 8 DRUG INTERACTIONS .................................................................................................. 17 DOSAGE AND ADMINISTRATION .............................................................................. 20 OVERDOSAGE ................................................................................................................ 21 ACTION AND CLINICAL PHARMACOLOGY ............................................................ 22 STORAGE AND STABILITY.......................................................................................... 24 SPECIAL HANDLING INSTRUCTIONS ....................................................................... 24 DOSAGE FORMS, COMPOSITION AND PACKAGING ....................... Olvassa el a teljes dokumentumot